103 related articles for article (PubMed ID: 17215074)
1. Reduction of tumorigenesis and invasion of human breast cancer cells by whey acidic protein (WAP).
Nukumi N; Iwamori T; Kano K; Naito K; Tojo H
Cancer Lett; 2007 Jul; 252(1):65-74. PubMed ID: 17215074
[TBL] [Abstract][Full Text] [Related]
2. Whey acidic protein (WAP) regulates the proliferation of mammary epithelial cells by preventing serine protease from degrading laminin.
Nukumi N; Iwamori T; Kano K; Naito K; Tojo H
J Cell Physiol; 2007 Dec; 213(3):793-800. PubMed ID: 17541952
[TBL] [Abstract][Full Text] [Related]
3. Regulatory function of whey acidic protein in the proliferation of mouse mammary epithelial cells in vivo and in vitro.
Nukumi N; Ikeda K; Osawa M; Iwamori T; Naito K; Tojo H
Dev Biol; 2004 Oct; 274(1):31-44. PubMed ID: 15355786
[TBL] [Abstract][Full Text] [Related]
4. A double WAP domain (DWD)-containing protein with proteinase inhibitory activity in Chinese white shrimp, Fenneropenaeus chinensis.
Du ZQ; Ren Q; Zhao XF; Wang JX
Comp Biochem Physiol B Biochem Mol Biol; 2009 Oct; 154(2):203-10. PubMed ID: 19545640
[TBL] [Abstract][Full Text] [Related]
5. Expression of the whey acidic protein (Wap) is necessary for adequate nourishment of the offspring but not functional differentiation of mammary epithelial cells.
Triplett AA; Sakamoto K; Matulka LA; Shen L; Smith GH; Wagner KU
Genesis; 2005 Sep; 43(1):1-11. PubMed ID: 16106354
[TBL] [Abstract][Full Text] [Related]
6. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
7. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice.
Zhang M; Shi Y; Magit D; Furth PA; Sager R
Oncogene; 2000 Dec; 19(52):6053-8. PubMed ID: 11146557
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells.
Zhang TF; Yu SQ; Deuel TF; Wang ZY
Anticancer Res; 2003; 23(5A):3735-40. PubMed ID: 14666671
[TBL] [Abstract][Full Text] [Related]
9. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the tammar wallaby (Macropus eugenii) whey acidic protein gene: new insights into the function of the protein.
Topcic D; Auguste A; De Leo AA; Lefevre C; Digby MR; Nicholas KR
Evol Dev; 2009; 11(4):363-75. PubMed ID: 19601970
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene.
Tzeng YJ; Guhl E; Graessmann M; Graessmann A
Oncogene; 1993 Jul; 8(7):1965-71. PubMed ID: 8390039
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro expression of human serum albumin genomic sequences in mammary epithelial cells with beta-lactoglobulin and whey acidic protein promoters.
Barash I; Faerman A; Richenstein M; Kari R; Damary GM; Shani M; Bissell MJ
Mol Reprod Dev; 1999 Mar; 52(3):241-52. PubMed ID: 10206655
[TBL] [Abstract][Full Text] [Related]
13. Molecular evolution of monotreme and marsupial whey acidic protein genes.
Sharp JA; Lefèvre C; Nicholas KR
Evol Dev; 2007; 9(4):378-92. PubMed ID: 17651362
[TBL] [Abstract][Full Text] [Related]
14. The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction.
Oztürk-Winder F; Renner M; Klein D; Müller M; Salmons B; Günzburg WH
Cancer Gene Ther; 2002 May; 9(5):421-31. PubMed ID: 11961665
[TBL] [Abstract][Full Text] [Related]
15. RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells.
Zhang TF; Yu SQ; Wang ZY
Anticancer Res; 2007; 27(5A):3205-9. PubMed ID: 17970062
[TBL] [Abstract][Full Text] [Related]
16. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
[TBL] [Abstract][Full Text] [Related]
19. In silico study of whey-acidic-protein domain containing oral protease inhibitors.
Idoji Y; Watanabe Y; Yamashita A; Yamanishi K; Nishiguchi S; Shimada K; Yasunaga T; Yamanishi H
Int J Mol Med; 2008 Apr; 21(4):461-8. PubMed ID: 18360692
[TBL] [Abstract][Full Text] [Related]
20. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
